Category Archives: PSA

Ten Things Physicians and Patients Should Question.

Posted on July 26, 2015 by

The “Chose Wisely” Israel Barken M.D., discusses the Choose Wisely program. The program created by cooperation between the American Board of Internal Medicine and the American Urological Association.

Posted in PSA, Sexual Dysfunction, Testosterone, Treatments for Prostate Cancer | Leave a comment

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Posted on April 24, 2015 by

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy. Author:  Anthony V. D’Amico Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment

Phase III Prostvac Clinical Study

Posted on December 18, 2014 by

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

New Prostate Cancer Immunotherapy- Prostvac

Posted on November 28, 2014 by

Dr. Barken introduces the New Prostate Cancer Immune Therapy for earlier stages of Prostate Cancer.  Please watch the video below and see what  he learned at the National Cancer Institute recent conference mentioned above. Dr. James Gulley explains the Prostvac … Continue reading →

Posted in Clinical Trials, Immune Therapy, Prostate Cancer, PSA, Treatments for Prostate Cancer | Tagged | Leave a comment

Enzalutamide and Prostvac for patients with PSA only disease after primary treatment

Posted on October 22, 2014 by

This very significant development could become the standard treatment for prostate cancer in the future.   Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer. NIH Study- Recruiting- ClinicalTrials.gov  Identifier: NCT01875250

Posted in Immune Therapy, Prostate Cancer, PSA, Radiation Therapy, Radical Prostatectomy | Leave a comment

Delaying Androgen Deprivation

Posted on June 30, 2014 by

Delaying Androgen Deprivation Therapy May not compromise Survival in Men with Prostate cancer and PSA-Only Relapse.

Posted in Hormonal Blockade, PSA, Radiation treatment, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged | Leave a comment

Active Surveillance- Canadian Experience Part 2.

Posted on May 9, 2014 by

  Active Surveillance:  Current status and future direction. Part 2. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday.      Click here to send me a question by sending a video.  Click to view instructions.

Posted in Active Surveillance, Biopsy, Imaging, PSA, Treatments for Prostate Cancer | Leave a comment

PSA Response to Neoadjuvant Androgen Deprivation Therapy iIs a Strong Predictor of Survival

Posted on June 2, 2013 by

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

Posted in Hormonal Blockade, Prognosis, Prostate Cancer, PSA, Radiation Therapy, Survival prostate cancer, Treatments for Prostate Cancer | Tagged | Leave a comment

RISING PSA AND THE USE OF PROSCAR

Posted on January 7, 2013 by

For the Ask Dr Barken Call In Show on Tuesday, Jan. 8th at 6pm Pacific- Dial 1-877-727-3301 to hear the program and speak with Dr. Barken.  You may leave a question before the show by dialing the same number and recording … Continue reading →

Posted in Prostate Cancer, PSA, Treatments for Prostate Cancer | Tagged | Leave a comment

Question: Shall I do a biopsy of the prostate?

Posted on February 7, 2012 by

The following question is for the Ask Dr Barken Call In Show on Tuesday, Feb. 7th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:   An email from a patient gave brief medical history and ended with … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Biopsy, Color Doppler Trans-Rectal Ultrasound, Decision Making, Diagnosis, Imaging, Markers, Prostate Cancer, PSA, Treatments for Prostate Cancer | Leave a comment